Dipeptides

dipeptidyl peptidase 4 ; Homo sapiens







92 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34920066 Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV. 2022 Jan 31 2
2 35149549 PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index. 2022 Apr 1 2
3 35309368 Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. 2022 1
4 34885056 The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells. 2021 Nov 26 2
5 34937822 Cellular expression of CD26/dipeptidyl peptidase IV. 2021 1
6 31709757 Structure-activity relationships study on biological activity of peptides as dipeptidyl peptidase IV inhibitors by chemometric modeling. 2020 Feb 2
7 31866290 Rapid detection of DPP-IV activity in porcine serum: A fluorospectrometric assay. 2020 Mar 1 2
8 32613113 Hydrophobic interactions at subsite S1' of human dipeptidyl peptidase IV contribute significantly to the inhibitory effect of tripeptides. 2020 Jun 2
9 32998057 Dipeptidyl peptidase-4 and GLP-1 interplay in STC-1 and GLUTag cell lines. 2020 Dec 1
10 29806214 Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. 2019 Jan 2
11 31357088 CD26 in autoimmune diseases: The other side of "moonlight protein". 2019 Oct 2
12 29426867 Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues. 2018 Feb 9 1
13 30242112 Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer. 2018 Nov 15 2
14 28122713 Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. 2017 Apr 1 1
15 28630069 Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4. 2017 Sep 1
16 29564006 Development of a fluorogenic small substrate for dipeptidyl peptidase-4. 2017 1
17 26919392 Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. 2016 Jul 4
18 26988064 Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation. 2016 Jun 3
19 27410463 Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approaches. 2016 Sep 1 2
20 27431629 [Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]. 2016 Jul 1
21 25577052 Analyzing a dipeptide library to identify human dipeptidyl peptidase IV inhibitor. 2015 May 15 2
22 25723507 Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors. 2015 2
23 24099035 Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? 2014 Mar 27 3
24 24200567 Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham. 2014 Feb 1
25 24929856 Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system. 2014 Aug 15 2
26 25140306 The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. 2014 2
27 23219487 Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. 2013 Jan 2
28 23268343 Systematic analysis of a dipeptide library for inhibitor development using human dipeptidyl peptidase IV produced by a Saccharomyces cerevisiae expression system. 2013 Jan 25 4
29 23579020 Interaction of dipeptydil peptidase IV with amyloid peptides. 2013 Jun 1
30 23768405 Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides. 2013 Nov 1 3
31 24193022 Inhibition of dipeptidyl peptidase IV (DPP-IV) by tryptophan containing dipeptides. 2013 Dec 5
32 22093941 Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors. 2012 Feb 18 3
33 22307932 Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs. 2012 Apr 2
34 22561447 Dipeptidyl peptidase-4 expression is reduced in Crohn's disease. 2012 Aug 20 2
35 22850530 Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury. 2012 Dec 4
36 23107693 Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran. 2012 Sep 15 1
37 21284559 Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site. 2011 Mar 2
38 21510839 Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein. 2011 2
39 19217790 Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. 2009 Mar 1 1
40 17981714 Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil? 2008 Jan 1 2
41 18520029 Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. 2008 Jun 1
42 18783201 Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety. 2008 Oct 9 1
43 23495778 Dipeptidyl peptidase-IV and related molecules: markers of malignancy? 2008 Jun 2
44 17258152 Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. 2007 Feb 2
45 17610364 Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. 2007 Jun 3
46 17786309 Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. 2007 Oct 1
47 16330047 Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV. 2006 Jan 27 1
48 16376077 Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1. 2006 Mar 15 1
49 16913724 Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach. 2006 Aug 24 3
50 16939389 Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes. 2006 Sep 1